You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Enfortumab vedotin

Showing 1 - 25 of 275
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Enfortumab vedotin
  • Kansas City, Kansas
    University of Kansas Cancer Center
Jun 23, 2023

Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab

Not yet recruiting
  • Urothelial Carcinoma
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jun 27, 2023

Metastatic Penile Squamous Cell Carcinoma, Stage III Penile Cancer AJCC v8, Stage IV Penile Cancer AJCC v8 Trial in Phoenix,

Not yet recruiting
  • Metastatic Penile Squamous Cell Carcinoma
  • +3 more
  • Enfortumab Vedotin
  • Phoenix, Arizona
  • +2 more
Oct 23, 2023

Adenocarcinoma of the Bladder, Squamous Cell Carcinoma of the Bladder, Testicular Germ Cell Tumors Trial run by the National

Not yet recruiting
  • Adenocarcinoma of the Bladder
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 22, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Enfortumab vedotin)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Enfortumab vedotin
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jan 24, 2023

Renal Pelvis and Ureter Urothelial Carcinoma Trial in Los Angeles (procedure, drug, biological)

Not yet recruiting
  • Renal Pelvis and Ureter Urothelial Carcinoma
  • Biopsy
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 15, 2023

Adults in South Korea With Cancer Who Receive PADCEV Injection

Recruiting
  • Urothelial Cancer
  • Enfortumab Vedotin
  • Seoul, Korea, Republic of
    KR82004
Aug 22, 2023

Urothelial Carcinoma Trial in United States (Enfortumab Vedotin, Radical surgery)

Not yet recruiting
  • Urothelial Carcinoma
  • Enfortumab Vedotin
  • Radical surgery
  • Basking Ridge, New Jersey
  • +6 more
May 11, 2023

Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation, Locally Advanced Urothelial Carcinoma, Metastatic

Recruiting
  • Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation
  • +3 more
  • Cabozantinib S-malate
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 8, 2022

Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Tumor Trial in Atlanta (procedure,

Not yet recruiting
  • Bladder Squamous Cell Carcinoma
  • +10 more
  • Biospecimen Collection
  • +5 more
  • Atlanta, Georgia
  • +3 more
Feb 20, 2023

Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Trial in

Recruiting
  • Urothelial Cancer
  • +3 more
  • Sacituzumab Govitecan (SG)
  • Enfortumab vedotin-ejfv (EV)
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 28, 2022

High Grade Urothelial Carcinoma, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore (Enfortumab

Not yet recruiting
  • High Grade Urothelial Carcinoma
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jan 5, 2023

Metastatic Urothelial Carcinoma, Urothelial Tumors Trial (Coformulated favezelimab/pembrolizumab, Coformulated

Not yet recruiting
  • Metastatic Urothelial Carcinoma
  • Urothelial Neoplasms
  • Coformulated favezelimab/pembrolizumab
  • +3 more
  • (no location specified)
Apr 26, 2023

Metastatic Urothelial Cancer Trial in China (Enfortumab vedotin)

Active, not recruiting
  • Metastatic Urothelial Cancer
  • Enfortumab vedotin
  • Beijing, China
  • +7 more
Aug 23, 2022

Urothelial Carcinoma Trial in United States (Enfortumab vedotin, Pembrolizumab)

Recruiting
  • Urothelial Carcinoma
  • Basking Ridge, New Jersey
  • +6 more
Jun 6, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +18 more
  • Los Angeles, California
  • +2 more
Jun 28, 2022

Cancer, Advanced Solid Tumor Trial in Kettering (lorlatinib, encorafenib + binimetinib, talazoparib)

Recruiting
  • Cancer
  • Advanced Solid Tumor
  • Kettering, Ohio
    Kettering Health Network
Oct 14, 2022

Bladder Cancer Trial in Japan (drug, procedure, radiation)

Not yet recruiting
  • Bladder Cancer
  • Kobe, Hyogo, Japan
  • +3 more
May 26, 2023

Advanced or Metastatic Solid Malignancies Trial in United States (Sitravatinib, Nivolumab, Pembrolizumab)

Enrolling by invitation
  • Advanced or Metastatic Solid Malignancies
  • Beverly Hills, California
  • +12 more
Aug 23, 2022

Carcinoma, Transitional Cell, Urinary Bladder Tumors, Urologic Tumors Trial in Worldwide (enfortumab vedotin (EV),

Active, not recruiting
  • Carcinoma, Transitional Cell
  • +6 more
  • enfortumab vedotin (EV)
  • +4 more
  • Anchorage, Alaska
  • +105 more
Dec 19, 2022

Metastatic Urothelial Cancer Trial in Japan (Enfortumab vedotin)

Completed
  • Metastatic Urothelial Cancer
  • Enfortumab vedotin
  • Tsukuba, Ibaraki, Japan
  • +7 more
Mar 2, 2020

Muscle Invasive Bladder Cancer Trial in Worldwide (biological, procedure, drug)

Recruiting
  • Muscle Invasive Bladder Cancer
  • Pembrolizumab
  • +4 more
  • Phoenix, Arizona
  • +136 more
Aug 5, 2022

Reporting of Antibody-Drug Conjugate Associated Sepsis-related

Completed
  • Sepsis (SMQ)
  • +2 more
  • Antibody-Drug Conjugate
  • Antineoplastic and immunomodulating agents other than Antibody-Drug Conjugate
  • Changsha, Hunan, China
    Central South University
Jun 19, 2022

Locally Advanced or Metastatic Urothelial Carcinoma (UC) Trial in United States (enfortumab vedotin (EV))

Approved for marketing
  • Locally Advanced or Metastatic Urothelial Carcinoma (UC)
  • enfortumab vedotin (EV)
  • Los Angeles, California
  • +14 more
Jan 9, 2020

Cisplatin-Ineligible Metastatic Bladder Cancer and The Role of

Not yet recruiting
  • Bladder Cancer
  • +3 more
  • Geriatric-8 Survey
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023